VCX After the Unlock: 28% of the Fund Traded in One Week, Then the Rally Faded
🔄 NAV update, August 28, 2026 — the denominator on this page has changed. Fundrise filed VCX's schedule of investments for June 30, 2026 on August 28, 2026: net assets $776,968,000 and NAV $21.70 per share, up 14.4% from the $18.97 reported for March 31, 2026. Premium figures on this page that were computed against $18.97 were correct for their dates, and are now computed against a superseded NAV. Against the June 30 figure, the August 28 close of $39.84 is a premium of 1.84x (83.6%), not the 2.10x (110.0%) the old denominator gives — a difference of about 26 percentage points. The fund's own prospectus supplement of September 10 gives a premium of 75.67% for September 8 ($38.12 against $21.70), and the September 11 close of $33.50 is 1.54x (54.4%), our arithmetic. Full position-by-position breakdown, at cost and at mark: VCX's NAV is $21.70, not $18.97.
Quick Answer
One full week after previously restricted Fundrise Innovation Fund (NYSE: VCX) shares became eligible to trade, the price was at a post-unlock high and the premium to the $18.97 net asset value then on file was the widest of the event to that date. VCX closed at $42.11 on Friday, August 21 (Nasdaq's settled figure), after a two-session pullback that bottomed at $39.42 on August 20. Friday's gain of 6.8% came on 883,915 shares, the first session since the unlock to trade more than the session before it. Across the six unlocked sessions VCX turned over 10,065,844 shares, about 28% of the entire fund. Against the SEC-filed NAV of $18.97 the premium was 122.0%, above the previous event high of 117.4% set on August 18, and about 54 percentage points above the 68.1% premium of the last session before holders could sell. Since then the fund has filed a June 30 NAV of $21.70 (August 28), and at the September 11, 2026 close of $33.50 the premium is about 54% (our arithmetic). The supply-wall thesis this site argued for months was not confirmed by the first week's tape. No 8-K or press release explains the August moves, and no Form 144 has been filed since the August 12 notice (EDGAR index checked September 12, 2026).
CSV · 8 rows
The data table in this article, as CSV
The 8-row table from this article as CSV: Session, Close, Premium to $18.97 NAV, Note. Sources are listed in the article.
The one-sentence version
Six sessions in, about 28% of the fund has changed hands and the price is 32% higher than it was the day before anyone could sell — so whatever the freed shares did, they did not overwhelm the bid, and the two-session dip that looked like a rollover on Wednesday was noise.
Same-day volume reads low: five sessions out of five
On the night of August 20 we published a volume range of 748,835 to 779,370 shares. The settled figure, now agreed by Nasdaq, StockAnalysis and Investing.com, is 802,127 — again above the top of our own range, by 2.9%.
That is five for five:
| Session | What we published on the night | Settled figure | Where the truth landed |
|---|---|---|---|
| August 14 | 3,820,606 to 3,863,203 | 3,863,203 | Top of the range |
| August 17 | 2,149,456 to 2,401,068 | 2,401,067 | Top of the range |
| August 18 | 1,095,837 to 1,241,755 | 1,274,701 | 32,946 shares ABOVE the range |
| August 20 | 748,835 to 779,370 | 802,127 | 22,757 shares ABOVE the range |
| August 21 | 816,810 to 853,770 | 883,915 | 30,145 shares ABOVE the range |
Same-day volume reads low, every time, and it settles upward. We had already identified that StockAnalysis settles late and settles toward Nasdaq. What five sessions now show is the stronger and more useful version: the whole cross-provider range on the night of a session is biased low, so a range is not the safe conservative choice it looks like. Publishing a range protects you from picking the wrong provider. It does not protect you from every provider being early.
The figures downstream of August 20 are corrected with it: the five settled unlocked sessions traded 9,181,929 shares — 25.65% of the fund, not the 25.5% we published, and August 20 was 3.65x the pre-unlock median rather than 3.41x to 3.55x.
The pattern held a fifth time: Friday's volume, published on the night as 816,810 to 853,770, settled at 883,915, above the range, and the "first session to trade more than the one before it" reading got stronger.
The two-session dip ended on Friday, and the thesis is now plainly wrong
This site published the supply-wall thesis: roughly 100,000 retail holders locked out of a fund trading at a large premium, and a wall of supply hitting a thin bid when the lockup lifted. For three sessions the tape ran directly against it, and we said so.
Then the price fell on August 19 and 20, and this page argued that the fall did not vindicate the thesis: it came on the two lightest sessions of the event, and a price drifting down on thinning volume is demand exhausting, not supply arriving.
Friday settled that argument in the least ambiguous way available. VCX rose 6.8% to $42.11, a new closing high for the event, on volume that was higher than Thursday's — the first session since the unlock to trade more than the one before it. A two-session, 4.4% pullback on falling volume was, in the end, a pause.
So the honest accounting, one week in, is not that our thesis is unconfirmed. It is that the tape has run against it in every measurable dimension:
- Price: we forecast pressure. At the August 21 close VCX was +32.0% on its last pre-unlock close (by September 11, at $33.50, it was +5.0%, our arithmetic).
- Premium: we forecast compression toward NAV. It widened from 68.1% to 122.0% (against the $18.97 NAV then on file), and Friday set the event high to that date.
- Supply: we forecast a wall that would overwhelm the bid. About 28% of the fund has changed hands and the bid took all of it at rising prices.
The one part that held up is the mechanical claim underneath it — that the unlock would produce enormous turnover. It did, on a scale even we did not model. The volume forecast was right and the price forecast was wrong, and the price forecast is the one that mattered.
Volume: the decay has not just stopped, it has reversed
Through the first three sessions the story was a clean halving: each session roughly half the one before. That broke, and then on Friday it inverted.
| Session | Volume | Multiple of the 219,826 median | Versus prior session, same provider |
|---|---|---|---|
| August 14 (1st unlocked) | 3,863,203 | 17.57x | record; 2.7x the old record |
| August 17 (2nd unlocked) | 2,401,067 | 10.92x | 62.2% |
| August 18 (3rd unlocked) | 1,274,701 | 5.80x | 53.1% |
| August 19 (4th unlocked) | 840,831 | 3.82x | 66.0% |
| August 20 (5th unlocked) | 802,127 | 3.65x | 95.4% |
| August 21 (6th unlocked) | 883,915 | 4.02x | 110.2% |
Read the last column downward: 62%, 53%, 66%, 95%, and then above 100%. The decay rate decayed to nothing and Friday turned it positive.
Extended naively, the first three sessions put VCX back at its pre-unlock median inside a week. We declined to extend it then, and that caution has been repaid: the fund is not going back to 220,000 shares a day. Through August 21 it settled at roughly 800,000 to 885,000, which is three and a half to four times its pre-unlock quiet volume, and held that level for three consecutive sessions rather than passing through it. Later sessions were lighter: 369,622 shares on September 11, still about 1.7 times the pre-unlock median (our arithmetic).
That is the durable change the unlock produced, and it is worth separating from the price entirely. Whatever VCX is worth, it is now a materially more liquid instrument than it was on August 12. About 100,000 holders who could not sell at any price now can, and 28% of the fund has already changed hands to establish where the clearing level is. The lockup was not just a restriction on selling; it was the thing suppressing the fund's normal turnover, and removing it appears to have reset that turnover about four-fold.
The premium after one week
For three sessions the premium to filed NAV went the wrong way for anyone expecting an unlock to compress it. It narrowed for two sessions. On Friday it made a new high.
| Session | Close | Premium to $18.97 NAV | Note |
|---|---|---|---|
| August 12, 2026 | $31.89 | 68.1% (1.68x) | Last clean pre-event close |
| August 13, 2026 | $38.50 | 103.0% (2.03x) | Lockup expiry; shares still locked |
| August 14, 2026 | $34.40 | 81.3% (1.81x) | First tradeable session; record volume |
| August 17, 2026 | $41.00 | 116.1% (2.16x) | Second tradeable session; 2nd-heaviest ever |
| August 18, 2026 | $41.25 | 117.4% (2.17x) | Widest of the event to that date |
| August 19, 2026 | $40.65 | 114.3% (2.14x) | First narrowing |
| August 20, 2026 | $39.42 | 107.8% (2.08x) | Second narrowing; lowest close since August 14 |
| August 21, 2026 | $42.11 | 122.0% (2.22x) | Widest of the first six unlocked sessions |
Two sessions of narrowing turned out not to be compression at all. The level is what matters more than the direction, and the level went one way that week: VCX traded at more than twice the $18.97 NAV then on file, about 54 percentage points wider than when its holders were locked out. An unlock that was supposed to close a 68.1% premium had, one full week later, widened it to 122.0%.
The NAV caveat has since been resolved in the direction it pointed: $18.97 is from the Form N-CSR for the period ended March 31, 2026, and on August 28 the fund filed a June 30 NAV of $21.70. Against it the August 21 close of $42.11 was a premium of 94.1%, and the September 11, 2026 close of $33.50 is 54.4% (our arithmetic).
Where the price sits now
Friday's close is the fund's highest since July 24, 2026 ($55.62) — the day Fundrise announced it was pulling the lockup expiration forward by a month, and the session before VCX fell 31.05%. Every session referenced here is in the complete VCX price record.
The shape of the last month is: a third of the fund comes off on the announcement, the fund grinds down to a closing low of $31.70 on August 11, the supply arrives on August 14 and sets an all-time low of $28.71, and the price then round-trips the entire acceleration selloff and keeps going, pausing only for two sessions on the way.
At the August 21 close of $42.11, VCX was:
- +32.0% on the last pre-unlock close ($31.89, August 12)
- +46.7% on the all-time low ($28.71, August 14)
- above the prior event peak ($41.25, August 18), by 2.1%
- −24.3% from the July 24 close of $55.62, the part of the fall the tape had not taken back
- −88.9% from the record close of $380.00 on March 25, 2026
At the September 11, 2026 close of $33.50 it is 5.0% above the pre-unlock close, 16.7% above the all-time low, 39.8% below the July 24 close and 91.2% below the record close (our arithmetic).
What we still cannot tell you
Why. Our standing view of the fund itself — its holdings, its fee load and its NAV history — is in the Fundrise VCX review. None of it explains this week either. The only SEC filings for CIK 1867090 dated after August 12, 2026 are the June 30 schedule of investments (August 28), a shelf registration (September 9) and an at-the-market prospectus supplement (September 10), per the filing index checked on September 12, 2026; none of them explains the August trading.
Whether the freed holders actually sold. A nine-million-share five-day period does not mean nine million shares were net sold by unlocked investors. Every trade has both sides, and sessions like these carry heavy intraday churn where the same block turns over repeatedly. What the tape establishes is that whatever supply came out was met, and met at prices well above where the fund traded before the unlock.
The document that would answer it
The next Form 144. The Fundrise-affiliated seller has filed roughly every nine days since late July: July 24, August 3, and August 12. On that cadence the next one was due around August 21. None has been filed: as of September 12, 2026 the most recent Form 144 on the CIK 1867090 index is still the August 12 notice.
The August 12 notice carried a complete daily record: 889,081 shares for $56,493,338, an average of $63.54, on 48 of the 49 sessions from June 2 to August 11, with the affiliate's share of daily volume climbing from 3.5% in June to a peak of 17.4% in early August. Our full breakdown is on the VCX Form 144 page. A notice covering August 13 to 20 would tell us whether the party that sold into every session of the decline also sold into the largest sessions the fund has ever had. Either answer is informative.
Frequently Asked Questions
Methodology
Every price and volume figure comes from the consolidated tape as published by Nasdaq, StockAnalysis and Investing.com, queried on the evening of August 21, 2026 after that session's close. August 20 is settled: all three providers agree exactly on open ($38.57), high ($40.98), low ($37.30), close ($39.42) and volume (802,127). August 21 has since settled: Nasdaq's history, re-read on September 12, 2026, shows a $42.11 close on 883,915 shares, above the top of the volume range published on the night.
Ranges from the night of a session are treated as biased low, not as a safe midpoint. On each of August 14, 17, 18, 20 and 21 the settled volume landed at or above the top of the range we published that evening, and on August 18, 20 and 21 it landed above the range entirely. The August 20 figure and everything computed from it are corrected on this page.
Session-over-session decay is computed provider against itself, never across providers. Medians are computed from the full tape of the sessions preceding August 14, back to the listing on March 19, 2026; the 20-session window is July 16 to August 12, 2026, chosen to match the baseline we published before the event so comparisons are like for like. NAV and shares outstanding are from the fund's Form N-CSR for the period ended March 31, 2026. The SEC filing index for CIK 1867090 was re-checked on September 12, 2026: the filings after the August 12 Form 144 are the NPORT-P of August 28, the N-2ASR of September 9 and the 424B2 of September 10, and no further Form 144.
We hold no position in VCX or DXYZ, long or short. Fundrise has no affiliate relationship with this site; an application through Impact was auto-rejected on August 13, 2026, which changes nothing about how we cover the fund. Nothing here is investment advice.
Last updated: September 12, 2026.
Keep reading.
- 0111 min read
Inland Private Capital DSTs, From 1,579 Form D Filings: $8.67 Billion Sold, a Load Back Up to 7.9%, and the Zero-Coupon Deals
Every Inland Private Capital (IPC) Delaware statutory trust that filed a Form D with the SEC from 2009 to September 2026: 215 DSTs that report $8.67 billion sold across 23,240 investor positions. Unlike most sponsors, IPC updates each Form D until the offering closes, so these are amounts actually raised. Median selling commission 6.0%, 7.9% on the 2025-2026 multifamily deals; payments to related persons median 6.75%, and about 24% on the 'Zero Coupon' DSTs.
- 0215 min read
Kingsbarn DSTs, From Their Own Form D Filings: 86 Offerings, the Sponsor's Fee on Your Cash, and Who Sells Them
Every Kingsbarn Delaware statutory trust that filed a Form D with the SEC from 2014 to September 17, 2026: 86 DSTs listing $2.07 billion, 21 of them since 2024 with $626.5 million reported sold to 464 investors (about $1.35 million each). Payments to the sponsor side median 8.0% of the offering, and 10.7%-21.2% of the cash investors put in where the form lets you measure it. All 21 recent filings say the interests may be sold by California real estate brokers who are not registered broker-dealers.
- 0313 min read
Accordant ODCE Index Fund (ODCEX): One $50 Million Class Now Owns 61%, the Fee Cap Ends October 30, and 73% of the Payout Was Your Own Money Back
Accordant ODCE Index Fund (ODCEX), the interval fund that buys into the big private core real estate funds of the NFI-ODCE index, grew from $46 million to $170.5 million in a year, $103 million of it in September 2025 into its $50 million-minimum Class Y. Its expense cap ends October 30, 2026 (Class I costs 1.67% without it, before the underlying funds' own fees), 73% of fiscal 2026 distributions were return of capital, and its quarterly exits sit on funds with redemption queues, including one its own sub-adviser is buying into at 95% of NAV.